tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
3 Small-Cap Stocks That Could Double Your Money, According to Analysts
PremiumMarket News3 Small-Cap Stocks That Could Double Your Money, According to Analysts
16d ago
Beam Therapeutics: Strong Buy Rating Backed by Promising Trials and Solid Financial Position
Premium
Ratings
Beam Therapeutics: Strong Buy Rating Backed by Promising Trials and Solid Financial Position
20d ago
Private Markets: Canva draws attention as IPO candidate following Figma debut
Premium
The Fly
Private Markets: Canva draws attention as IPO candidate following Figma debut
21d ago
Beam Therapeutics reports Q2 EPS ($1.00), consensus ($1.09)
PremiumThe FlyBeam Therapeutics reports Q2 EPS ($1.00), consensus ($1.09)
24d ago
Beam Therapeutics provides updata on BEAM-302 development progress
Premium
The Fly
Beam Therapeutics provides updata on BEAM-302 development progress
24d ago
Analysts Spot 3 Strong Buy Russell 2000 Stocks with 100% Upside
Premium
Market News
Analysts Spot 3 Strong Buy Russell 2000 Stocks with 100% Upside
1M ago
Beam Therapeutics Acquires Early-Stage Life Sciences Firm
PremiumCompany AnnouncementsBeam Therapeutics Acquires Early-Stage Life Sciences Firm
2M ago
Cathie Wood’s ARK Investment buys 55K shares of Beam Therapeutics today
Premium
The Fly
Cathie Wood’s ARK Investment buys 55K shares of Beam Therapeutics today
2M ago
Beam Therapeutics: Advancements in Gene Editing and Promising Clinical Milestones Justify Buy Rating
Premium
Ratings
Beam Therapeutics: Advancements in Gene Editing and Promising Clinical Milestones Justify Buy Rating
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100